An interventional study of Mepilex and LiquiCell in Pressure Injury and Military Activity, sponsored by University of Washington. Terminated at 1 site in United States. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-16.
Sponsored by University of Washington · Not applicable, Interventional, and Other
This study evaluates the effect of a multilayer skin dressing (Mepilex) placed on the sacrum or a fluid filled pad (LiquiCell) on risk factors for pressure injuries under conditions consistent with military long-distance transport or prolonged field care. Participants will be assigned to one of six groups - air transport, air transport on a spinal immobilization surface with or without Mepilex or on a field stretcher with or without LiquiCell.
Combat casualties undergoing long distance aeromedical evacuation (AE), particularly casualties who are immobilized because of possible spine injuries, and casualties who required prolonged field care are at increased risk for pressure injuries. The risk factors pressure and shear are potentially modifiable via solutions appropriate for these austere conditions. Two interventions (Mepilex and LiquiCell) will be evaluated under conditions simulating military medical transport on a standard stretcher or with spinal immobilization in a vacuum spine board (VSB) or on a military stretcher used under field conditions. Mepilex is a multi-layer dressing that can be placed on the skin (sacrum/buttocks) and LiquiCell is a pad filled with pockets of fluid that is placed under the back and buttocks. The effect of these interventions compared to not using them will be studied under the three conditions with or without the intervention (Mepilex or LiquiCell) using measures obtained on the lower back/sacrum including skin interface pressure, oxygen, moisture, and temperature and a cytokine indicating possible tissue damage.
518 studies on the registry are indexed under Pressure Ulcer; 117 are open to participants now.
This study's enrollment of 72 is close to the median of 70 across 395 interventional studies indexed under Pressure Ulcer.
Browse Pressure Ulcer studies →University of Washington is the lead sponsor of 1,397 studies on the registry; 225 are open to participants now.
Of its 154 completed or terminated interventional studies of FDA-regulated products, 132 (86%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria
Intervention: Mepilex
Device: Mepilex
Intervention: Control (no Mepilex)
Intervention: Mepilex
Device: Mepilex
Intervention: Control (no Mepilex)
Intervention: LiquiCell mat
Device: LiquiCell
Intervention: Control (no LiquiCell)
Mepilex Border Sacrum dressing is a multi-layered soft silicone dressing that is a recommended strategy to augment standard nursing interventions (i.e., repositioning, offloading) to prevent pressure injuries. The dressing will be placed on the sacrum.
LiquiCell is a thin layer of low-viscosity fluid contained in a series of bursa-like pouches. Baffles within each pouch channel the liquid to disperse pressure and the volume of liquid in the pouch is so small that there is no pressure-build up. LiquiCell is available commercially as a 36 X 18-inch mattress overlay (LiquiCell Shear Reducing Mattress Overlay) with a soft pliable top and a non-slip bottom. The overlay is positioned from the shoulders to below the hips to minimize shear.
Change in Interleukin-1/Total Protein (Skin)
Skin cytokine (IL-1) and total protein will be obtained using a small strip of specialized tape placed on the sacrum/buttocks. After 1-minute application the tape is removed and analyzed for quantity of interleukin-1 (indicator of skin irritation)
Time frame: Baseline through study completion - approximately 120 minutes
Change in Transcutaneous Tissue Oxygen (TcPO2)
Tissue oxygen is measured continuously on the sacrum using a noninvasive sensor and on the midsternum (midchest) as a control
Time frame: Measured continuously during the baseline (sidelying), supine (120 minutes) and post-sidelying (15 minutes) periods
Change in Skin Moisture (Epidermal and Subepidermal)
Two components of skin moisture will be measured on the sacrum using the Delfin MoistureMeter. The epidermal moisture, which reflects perspiration and subepidermal moisture , which reflects water content of the tissues. The values range from 1-80, with higher numbers reflecting increased moisture.
Time frame: Baseline (before lying down) and after 120 minutes supine
Change in Skin Temperature
Skin temperature will be measured continuously on the sacrum using a laser doppler probe.
Time frame: Measured continuously during the baseline (sidelying), supine (120 minutes) and post-sidelying (15 minutes) periods
Change in Skin Interface Pressure
The pressure between the support surface and the skin will be measured continuously during the supine position using the X Sensor system. This system measures force/unit area (e.g., pressure). The peak and average pressure on the sacrum/buttocks will be measured.
Time frame: Continuously during the supine phase of the study (120 minutes)
Change in Pressure-Discomfort (Category Partitioning Scale-50)
This scale asks the participant to describe in verbal terms the pressure intensity or discomfort associated with the stimulus (i.e., sacral/buttocks pressure or discomfort). The participant can then fine tune their assessment using a numeric score. The final score is an analog. The score ranges from 0-52, with higher scores indicating higher pressure or more severe discomfort. The investigator will ask the participant to limit their evaluation to the pressure/discomfort sensed on the sacrum/buttocks, but the investigator will also ask the participants to identify on their body where they are experiencing the most pressure/discomfort.
Time frame: The score will be obtained at baseline and every 30 minutes in the supine position (total 5 measurements).
| Milestone | Group 1: Mepilex on Litter + WELP Mattress + 30 Degree Backrest | Group 2: Without Mepilex on Litter + WELP Mattress +30 Degree Backrest | Group 3: Mepilex on VSB on WELP Mattress | Group 4: Without Mepilex on VSB on WELP Mattress | Group 5 Prolonged Field Care (PFC) - LiquiCell on Talon Litter | Group 6: PFC Without LiquiCell on Talon Litter |
|---|---|---|---|---|---|---|
| Started | 12 | 12 | 12 | 12 | 12 | 12 |
| Completed | 10 | 9 | 9 | 8 | 9 | 9 |
| Not completed | 2 | 3 | 3 | 4 | 3 | 3 |
| Withdrew: Study closed due to pandemic with approval of funding agency/irb | 2 | 3 | 3 | 4 | 3 | 3 |
Skin cytokine (IL-1) and total protein will be obtained using a small strip of specialized tape placed on the sacrum/buttocks. After 1-minute application the tape is removed and analyzed for quantity of interleukin-1 (indicator of skin irritation)
| Ratio | Group 1: Mepilex on Litter + WELP Mattress + 30 Degree Backrest | Group 2: Without Mepilex on Litter + WELP Mattress +30 Degree Backrest | Group 3: Mepilex on VSB on WELP Mattress | Group 4: Without Mepilex on VSB on WELP Mattress | Group 5 Prolonged Field Care (PFC) - LiquiCell on Talon Litter | Group 6: PFC Without LiquiCell on Talon Litter |
|---|---|---|---|---|---|---|
| Change in Interleukin-1/Total Protein (Skin) | -1.9 ± 2.7 | -0.8 ± 2.7 | 0.13 ± 2.4 | -4 ± 2.2 | -3.5 ± 2.7 | 0.14 ± 0.3 |
Tissue oxygen is measured continuously on the sacrum using a noninvasive sensor and on the midsternum (midchest) as a control
| mm Hg | Group 1: Mepilex on Litter + WELP Mattress + 30 Degree Backrest | Group 2: Without Mepilex on Litter + WELP Mattress +30 Degree Backrest | Group 3: Mepilex on VSB on WELP Mattress | Group 4: Without Mepilex on VSB on WELP Mattress | Group 5 Prolonged Field Care (PFC) - LiquiCell on Talon Litter | Group 6: PFC Without LiquiCell on Talon Litter |
|---|---|---|---|---|---|---|
| Change in Transcutaneous Tissue Oxygen (TcPO2) | -15 ± 26 | -25 ± 25 | -4 ± 23 | -6 ± 16 | -54 ± 24 | -53 ± 17 |
Two components of skin moisture will be measured on the sacrum using the Delfin MoistureMeter. The epidermal moisture, which reflects perspiration and subepidermal moisture , which reflects water content of the tissues. The values range from 1-80, with higher numbers reflecting increased moisture.
| Tissue Dielectric Constant (TDC) | Group 1: Mepilex on Litter + WELP Mattress + 30 Degree Backrest | Group 2: Without Mepilex on Litter + WELP Mattress +30 Degree Backrest | Group 3: Mepilex on VSB on WELP Mattress | Group 4: Without Mepilex on VSB on WELP Mattress | Group 5 Prolonged Field Care (PFC) - LiquiCell on Talon Litter | Group 6: PFC Without LiquiCell on Talon Litter |
|---|---|---|---|---|---|---|
| Change in Skin Moisture (Epidermal and Subepidermal) | 1.5 ± 2 | 2 ± 3.8 | 1.1 ± 2.2 | 2.1 ± 2.8 | -0.1 ± 2 | 0.1 ± 1.3 |
Skin temperature will be measured continuously on the sacrum using a laser doppler probe.
| Degrees centigrade | Group 1: Mepilex on Litter + WELP Mattress + 30 Degree Backrest | Group 2: Without Mepilex on Litter + WELP Mattress +30 Degree Backrest | Group 3: Mepilex on VSB on WELP Mattress | Group 4: Without Mepilex on VSB on WELP Mattress | Group 5 Prolonged Field Care (PFC) - LiquiCell on Talon Litter | Group 6: PFC Without LiquiCell on Talon Litter |
|---|---|---|---|---|---|---|
| Change in Skin Temperature | 3.8 ± 1.3 | 3.1 ± 1 | 3.7 ± 0.8 | 3.2 ± 1 | 2 ± 2 | 1.1 ± 0.9 |
The pressure between the support surface and the skin will be measured continuously during the supine position using the X Sensor system. This system measures force/unit area (e.g., pressure). The peak and average pressure on the sacrum/buttocks will be measured.
| mm Hg | Group 1: Mepilex on Litter + WELP Mattress + 30 Degree Backrest | Group 2: Without Mepilex on Litter + WELP Mattress +30 Degree Backrest | Group 3: Mepilex on VSB on WELP Mattress | Group 4: Without Mepilex on VSB on WELP Mattress | Group 5 Prolonged Field Care (PFC) - LiquiCell on Talon Litter | Group 6: PFC Without LiquiCell on Talon Litter |
|---|---|---|---|---|---|---|
| Change in Skin Interface Pressure | 46 ± 8 | 52 ± 10 | 52 ± 10 | 66 ± 22 | 66 ± 27 | 78 ± 47 |
This scale asks the participant to describe in verbal terms the pressure intensity or discomfort associated with the stimulus (i.e., sacral/buttocks pressure or discomfort). The participant can then fine tune their assessment using a numeric score. The final score is an analog. The score ranges from 0-52, with higher scores indicating higher pressure or more severe discomfort. The investigator will ask the participant to limit their evaluation to the pressure/discomfort sensed on the sacrum/buttocks, but the investigator will also ask the participants to identify on their body where they are experiencing the most pressure/discomfort.
| Scores on a scale | Group 1: Mepilex on Litter + WELP Mattress + 30 Degree Backrest | Group 2: Without Mepilex on Litter + WELP Mattress +30 Degree Backrest | Group 3: Mepilex on VSB on WELP Mattress | Group 4: Without Mepilex on VSB on WELP Mattress | Group 5 Prolonged Field Care (PFC) - LiquiCell on Talon Litter | Group 6: PFC Without LiquiCell on Talon Litter |
|---|---|---|---|---|---|---|
| Change in Pressure-Discomfort (Category Partitioning Scale-50) | 7.7 ± 8.1 | 8 ± 10.4 | 9.1 ± 7.3 | 5.4 ± 4.2 | 8.7 ± 13.4 | 12.3 ± 11.1 |
Collected over 120 minutes. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Group 1: Mepilex on Litter + WELP Mattress + 30 Degree Backrest | 0/10 (0%) | 0/10 (0%) | 0/10 (0%) |
| Group 2: Without Mepilex on Litter + WELP Mattress +30 Degree Backrest | 0/9 (0%) | 0/9 (0%) | 0/9 (0%) |
| Group 3: Mepilex on VSB on WELP Mattress | 0/9 (0%) | 0/9 (0%) | 0/9 (0%) |
| Group 4: Without Mepilex on VSB on WELP Mattress | 0/8 (0%) | 0/8 (0%) | 0/8 (0%) |
| Group 5 Prolonged Field Care (PFC) - LiquiCell on Talon Litter | 0/9 (0%) | 0/9 (0%) | 0/9 (0%) |
| Group 6: PFC Without LiquiCell on Talon Litter | 0/9 (0%) | 0/9 (0%) | 0/9 (0%) |
All individuals with baseline data
| Age, Continuous(years) | Group 1: Mepilex on Litter + WELP Mattress + 30 Degree Backrest | Group 2: Without Mepilex on Litter + WELP Mattress +30 Degree Backrest | Group 3: Mepilex on VSB on WELP Mattress | Group 4: Without Mepilex on VSB on WELP Mattress | Group 5 Prolonged Field Care (PFC) - LiquiCell on Talon Litter | Group 6: PFC Without LiquiCell on Talon Litter | Total |
|---|---|---|---|---|---|---|---|
| Mean | 29.0 ± 10.6 | 26.7 ± 7.3 | 25.3 ± 12.3 | 24.8 ± 5.9 | 23.9 ± 8.8 | 25 ± 8 | 29 ± 12 |
| Sex: Female, Male(Participants) | Group 1: Mepilex on Litter + WELP Mattress + 30 Degree Backrest | Group 2: Without Mepilex on Litter + WELP Mattress +30 Degree Backrest | Group 3: Mepilex on VSB on WELP Mattress | Group 4: Without Mepilex on VSB on WELP Mattress | Group 5 Prolonged Field Care (PFC) - LiquiCell on Talon Litter | Group 6: PFC Without LiquiCell on Talon Litter | Total |
|---|---|---|---|---|---|---|---|
| Female | 8 | 6 | 6 | 6 | 6 | 8 | 40 |
| Male | 2 | 3 | 3 | 2 | 3 | 1 | 14 |
| Ethnicity (NIH/OMB)(Participants) | Group 1: Mepilex on Litter + WELP Mattress + 30 Degree Backrest | Group 2: Without Mepilex on Litter + WELP Mattress +30 Degree Backrest | Group 3: Mepilex on VSB on WELP Mattress | Group 4: Without Mepilex on VSB on WELP Mattress | Group 5 Prolonged Field Care (PFC) - LiquiCell on Talon Litter | Group 6: PFC Without LiquiCell on Talon Litter | Total |
|---|---|---|---|---|---|---|---|
| Hispanic or Latino | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
| Not Hispanic or Latino | 10 | 8 | 9 | 8 | 9 | 9 | 53 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | Group 1: Mepilex on Litter + WELP Mattress + 30 Degree Backrest | Group 2: Without Mepilex on Litter + WELP Mattress +30 Degree Backrest | Group 3: Mepilex on VSB on WELP Mattress | Group 4: Without Mepilex on VSB on WELP Mattress | Group 5 Prolonged Field Care (PFC) - LiquiCell on Talon Litter | Group 6: PFC Without LiquiCell on Talon Litter | Total |
|---|---|---|---|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Asian | 3 | 5 | 5 | 5 | 4 | 4 | 26 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Black or African American | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| White | 6 | 3 | 3 | 2 | 5 | 5 | 24 |
| More than one race | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
| Unknown or Not Reported | 0 | 1 | 1 | 0 | 0 | 0 | 2 |
| Body Fat Percent(Percent body fat) | Group 1: Mepilex on Litter + WELP Mattress + 30 Degree Backrest | Group 2: Without Mepilex on Litter + WELP Mattress +30 Degree Backrest | Group 3: Mepilex on VSB on WELP Mattress | Group 4: Without Mepilex on VSB on WELP Mattress | Group 5 Prolonged Field Care (PFC) - LiquiCell on Talon Litter | Group 6: PFC Without LiquiCell on Talon Litter | Total |
|---|---|---|---|---|---|---|---|
| Mean | 29 ± 10.6 | 26.7 ± 7.3 | 25.3 ± 12.3 | 24.8 ± 5.9 | 23.9 ± 8.8 | 25.0 ± 8.0 | 25.8 ± 8.9 |
Documents are hosted by the registry — open the source record to download them.
Plan to share: No
This study is terminated, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Washington